
Keywords: BCS; biopharmaceutics classification system; DoE; design of experiment; FASSIF; fasted simulated intestinal fluid; FESSIF; fed simulated intestinal fluid; IVIVC; in vitro in vivo correlation; GIT; gastrointestinal tract; API; active pharmaceutical ingredi